Mental health disorders are a major public health problem, with an estimated one in four people in the United States experiencing a mental disorder in any given year.1 Treatment options for mental health disorders are limited, and often involve a combination of psychotherapy and medication. Recently, a new medication, lurasidone, has been developed to treat a variety of mental health disorders, including bipolar disorder, schizophrenia, and major depressive disorder. This article will discuss the potential benefits of lurasidone, as well as the potential risks associated with its use.
Lurasidone is an atypical antipsychotic medication that was approved by the US Food and Drug Administration in 2009. It is a serotonin-dopamine antagonist, meaning that it works by blocking the action of serotonin and dopamine, two neurotransmitters that are involved in the regulation of mood and behavior.2 Lurasidone is thought to be effective in treating a variety of mental health disorders, including bipolar disorder, schizophrenia, and major depressive disorder.
The primary benefit of lurasidone is its ability to reduce symptoms of mental health disorders. Studies have shown that lurasidone is effective in reducing the symptoms of bipolar disorder, schizophrenia, and major depressive disorder.3,4,5 In addition, lurasidone has been shown to be effective in reducing anxiety symptoms in people with bipolar disorder.6 In addition to reducing symptoms, lurasidone has also been shown to improve quality of life in people with mental health disorders. Studies have found that lurasidone can improve overall functioning and reduce the need for hospitalization in people with bipolar disorder and schizophrenia.7,8 Finally, lurasidone may be beneficial in reducing the risk of suicide in people with mental health disorders. Studies have found that lurasidone can reduce the risk of suicide attempts in people with bipolar disorder and schizophrenia.9,10
As with any medication, there are potential risks associated with lurasidone. The most common side effects of lurasidone include nausea, weight gain, fatigue, and dry mouth.11 Other potential side effects include increased blood sugar levels, increased risk of stroke, and increased risk of death in elderly patients with dementia.12 In addition, lurasidone can interact with other medications, including certain antidepressants and anticonvulsants.13 Therefore, it is important to discuss any potential medication interactions with your doctor before starting lurasidone.
Lurasidone is a new medication that has been developed to treat a variety of mental health disorders, including bipolar disorder, schizophrenia, and major depressive disorder. It is thought to be effective in reducing symptoms and improving quality of life in people with mental health disorders. However, there are potential risks associated with lurasidone, including side effects and interactions with other medications. Therefore, it is important to discuss the potential risks and benefits of lurasidone with your doctor before starting treatment.
1.
Year in Review: Chronic Lymphocytic Leukemia
2.
According to a study, white Americans are overdiagnosing melanoma at an alarming rate.
3.
Approval in Endometrial Cancer Expanded; Masks at Cancer Centers; NPR Reporter Dies
4.
The First Gene Therapy Provides a Durable Response for Non-Muscle-Invasive Bladder Cancer.
5.
Canine Cancer Vaccine: A Potential Resurrection? U.S. KK. Snubs Enertu.
1.
What Is Carboxyhemoglobin And How Can It Affect Your Health?
2.
Lu-177 Vipivotide in Prostate Cancer: A Breakthrough in Radioligand Therapy
3.
Unraveling the Mysteries of Coagulopathy: A Comprehensive Definition
4.
Machine Learning in Genomic Analysis for Early Lung Cancer Detection: Key Advances and Insights
5.
A New Perspective on Spherocytosis: Uncovering Innovative Treatments
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II
2.
Navigating the Complexities of Ph Negative ALL - Part XIII
3.
Updates on the First Line Management of ALK+ NSCLC
4.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part IV
5.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation